DOI: 10.1055/s-00000094

Zeitschrift für Gastroenterologie

References

Saltz L. et al.
Phase III trial of cetuximab, bevacizumab, and 5-fluorouracil/leucovorin vs. FOLFOX-bevacizumab in colorectal cancer.

Clin Colorectal Cancer 2012;
11: 101-111

Download Bibliographical Data

Search in:
Access: